RecruitingNot ApplicableNCT03371121

Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

Valutazione Dell'Epidemiologia e Dei Risultati Radiografici e Clinici Nel Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC


Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Enrollment

103 participants

Start Date

Apr 26, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Age over 18 years
  • males and females
  • patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus

Exclusion Criteria2

  • age \<18 years at the time of surgery
  • patients with previous surgery on the affected ankle

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)

to fill arthroscopically osteochondral talar lesion


Locations(1)

Federico Usuelli

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03371121


Related Trials